Lower Serum Antibodies Against Tau Protein and Heavy Neurofilament in Alzheimer’s Disease

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works

A compendium of neuropsychological tests: administration, norms, and commentary

(1991) · Choice Reviews Online · doi:10.5860/choice.29-2400 · Cited by 6,117 · see citing works

The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening

Mioshi, E., Dawson, K., Mitchell, J., Arnold, R., & Hodges, J. R. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1610 · Cited by 2,016 · see citing works

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

Scheltens, P., Leys, D., Barkhof, F., Huglo, D. G., Weinstein, H. C., Vermersch, P., Kuiper, M. A., Steinling, M., Wolters, E. C., & Valk, J. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.10.967 · Cited by 1,781 · see citing works

Tau Consists of a Set of Proteins with Repeated C-Terminal Microtubule-Binding Domains and Variable N-Terminal Domains

Himmler, A., Drechsel, D. N., Kirschner, M. W., & Martin, D. W. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1381-1388.1989 · Cited by 535 · see citing works

Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements

Asuni, A. A., Boutajangout, A., Quartermain, D., & Sigurdsson, E. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2361-07.2007 · Cited by 506 · see citing works

Antibodies and neuronal autoimmune disorders of the CNS

Graus, F., Saiz, A., & Dalmau, J. O. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5431-9 · Cited by 388 · see citing works

Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial

Novák, P., Schmidt, R., Kontseková, E., Žilka, N., Kováčech, B., Škrabana, R., Kazmerova, Z., Katina, S., Fialová, Ľ., Prčina, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30331-3 · Cited by 306 · see citing works

Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model

Boutajangout, A., Quartermain, D., & Sigurdsson, E. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4363-10.2010 · Cited by 272 · see citing works

Paired helical filaments from Alzheimer disease patients contain cytoskeletal components.

Perry, G. L., Rizzuto, N., AUTILIO‐GAMBETTI, L., & Gambetti, P. L. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3916 · Cited by 215 · see citing works

Tauopathy-like Abnormalities and Neurologic Deficits in Mice Immunized With Neuronal Tau Protein

Rosenmann, H., Grigoriadis, N., Karussis, D., Boimel, M., Touloumi, O., Ovadia, H., & Abramsky, O. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1459 · Cited by 178 · see citing works

Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice

Boimel, M., Grigoriadis, N., Lourbopoulos, A., Haber, E., Abramsky, O., & Rosenmann, H. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.05.010 · Cited by 174 · see citing works

Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE

van Zwam, M., Huizinga, R., Melief, M., Wierenga‐Wolf, A. F., van Meurs, M., Voerman, J. S. A., Biber, K. P. H., Boddeke, H. W. G. M., Höpken, U. E., Meisel, C., et al. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0421-4 · Cited by 144 · see citing works

Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit

Silber, E., Semra, Y. K., Gregson, N. A., & Sharief, M. K. (2002) · Neurology · doi:10.1212/wnl.58.9.1372 · Cited by 143 · see citing works

Circulating Autoantibodies to the 200,000-Dalton Protein of Neurofilaments in the Serum of Healthy Individuals

Stefánsson, K., Marton, L. S., Dieperink, M. E., Molnar, G. K., Schlaepfer, W. W., & Helgason, C. M. (1985) · Science · doi:10.1126/science.4039466 · Cited by 117 · see citing works

Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood–brain barrier breakdown

Levin, E. C., Acharya, N. K., Han, M. C., Zavareh, S., Sedeyn, J. C., Venkataraman, V., & Nagele, R. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.038 · Cited by 113 · see citing works

Autoimmunity in Alzheimer’s disease: increased levels of circulating IgGs binding Aβ and RAGE peptides

Mruthinti, S., Buccafusco, J. J., Hill, W., Waller, J. L., Jackson, T. W., ZAMRINI, E. Y., & Schade, R. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.001 · Cited by 113 · see citing works

Add Alzheimer's disease to the list of autoimmune diseases

D’Andrea, M. R. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.024 · Cited by 113 · see citing works

A Systematic Review and Meta-Analysis of CSF Neurofilament Protein Levels as Biomarkers in Dementia

Petzold, A., Keir, G., Warren, J. D., Fox, N. C., & Rossor, M. N. (2007) · Neurodegenerative Diseases · doi:10.1159/000101843 · Cited by 112 · see citing works

Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: Autoantibodies to Aβ(25–35) oligomers, S100b and neurotransmitters

Алексеевна, Г. М., Davidova, T. B., Mališauskas, M., Sewell, R. D. E., Voskresenskaya, N. I., Wilhelm, K., Elistratova, E. I., Sherstnev, V. V., & Morozova‐Roche, L. A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.03.023 · Cited by 112 · see citing works

Natural human antibodies to amyloid beta peptide

Szabo, P., Relkin, N. R., & Weksler, M. E. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.03.007 · Cited by 107 · see citing works

Autoantibodies in Neurodegenerative Diseases: Antigen-Specific Frequencies and Intrathecal Analysis

Terryberry, J. W., Thor, G. T., & Peter, J. B. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00049-9 · Cited by 105 · see citing works

Tau as a Therapeutic Target for Alzheimers Disease

Boutajangout, A., Sigurdsson, E. M., & Krishnamurthy, P. K. (2011) · Current Alzheimer Research · doi:10.2174/156720511796717195 · Cited by 97 · see citing works

Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications

Jianming, W., & Ling, L. (2016) · The Journal of Biomedical Research · doi:10.7555/jbr.30.20150131 · Cited by 87 · see citing works

Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects

Rosenmann, H., Meiner, Z., Geylis, V., Abramsky, O., & Steinitz, M. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.072 · Cited by 77 · see citing works

Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe

Hort, J., Bartoš, A., Pirttilä, T., & Scheltens, P. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02753.x · Cited by 73 · see citing works

CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease

Rosenmann, H. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9665-5 · Cited by 68 · see citing works

Immunization With Neurofilament Light Protein Induces Spastic Paresis and Axonal Degeneration in Biozzi ABH Mice

Huizinga, R., Heijmans, N., Schubert, P., Gschmeissner, S., Hart, B. A. ‘., Herrmann, H. O., & Amor, S. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318040ad5c · Cited by 65 · see citing works

Autoimmune Responses to Amyloid Structures of Aβ(25–35) Peptide and Human Lysozyme in the Serum of Patients with Progressive Alzheimer’s Disease

Алексеевна, Г. М., Davudova, T. B., Mališauskas, M., Zamotin, V., Sewell, R. D. E., Voskresenskaya, N. I., Kostanyan, I. A., Sherstnev, V. V., & Morozova‐Roche, L. A. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000079197 · Cited by 65 · see citing works

Brain-Reactive Autoantibodies Prevalent in Human Sera Increase Intraneuronal Amyloid-β1-42 Deposition

Nagele, R. G., Clifford, P. M., Siu, G., Levin, E. C., Acharya, N. K., Han, M. C., Kosciuk, M. C., Venkataraman, V., Zavareh, S., Zarrabi, S., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110098 · Cited by 65 · see citing works

Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression

Colasanti, T., Barbati, C., Rosano, G. M. C., Malorni, W., & Ortona, E. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.07.008 · Cited by 61 · see citing works

Elevated intrathecal antibodies against the medium neurofilament subunit in multiple sclerosis

Bartoš, A., Fialová, L., Soukupová, J., Kukal, J., Malbohan, I. M., & Piťha, J. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0185-0 · Cited by 55 · see citing works

The Mini-Mental State Examination: Czech Norms and Cutoffs for Mild Dementia and Mild Cognitive Impairment due to Alzheimer's Disease

Bartoš, A., & Raisová, M. (2016) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000446426 · Cited by 47 · see citing works

Antibodies against light neurofilaments in multiple sclerosis patients

Bartoš, A., Fialová, L., Soukupová, J., Kukal, J., Malbohan, I. M., & ha, J. P. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00794.x · Cited by 45 · see citing works

Resistance is futile: antineuronal autoimmunity in multiple sclerosis.

Huizinga, R., Linington, C., & Amor, S. (2008) · Trends in immunology · doi:10.1016/j.it.2007.11.002 · Cited by 43 · see citing works

Low Avidity and Level of Serum Anti-A?? Antibodies in Alzheimer Disease

Lv, J., Yao, Z., Wei, Q., Zhikai, C., Jie, X., & Jinbiao, L. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200607000-00001 · Cited by 42 · see citing works

The innate and adaptive immunological aspects in neurodegenerative diseases

Rodrigues, M. C. O., Sanberg, P. R., Cruz, L. E. G., & Garbuzova-Davis, S. N. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.020 · Cited by 41 · see citing works

Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer’s Disease?

Papuć, E., Kurys-Denis, E., Krupski, W., Tatara, M. R., & Rejdak, K. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150309 · Cited by 33 · see citing works

Antibodies to the neuronal cytoskeleton are elicited by Alzheimer paired helical filament fractions

Perry, G. L., Friedman, R., Kang, D. H., Manetto, V., AUTILIO‐GAMBETTI, L., & Gambetti, P. L. (1987) · Brain Research · doi:10.1016/0006-8993(87)91243-1 · Cited by 33 · see citing works

Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease

Marcello, A., Wirths, O., Schneider-Axmann, T., Degerman-Gunnarsson, M., Lannfelt, L., & Bayer, T. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.011 · Cited by 29 · see citing works

Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia

Kronimus, Y., Albus, A., Balzer‐Geldsetzer, M., Straub, S., Semler, E., Otto, M., Klotsche, J., Dodel, R. C., & Mengel, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164953 · Cited by 26 · see citing works

Antibodies to different isoforms of the heavy neurofilament protein (NF-H) in normal aging and Alzheimer's disease

Soussan, L., Tchernakov, K., Lavi, O., Yuvan, T., Wertman, E., & Michaelson, D. M. (1994) · Molecular Neurobiology · doi:10.1007/bf02816107 · Cited by 26 · see citing works

Increased Intrathecal High-Avidity Anti-Tau Antibodies in Patients with Multiple Sclerosis

Fialová, L., Bartoš, A., Švarcová, J., & Malbohan, I. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027476 · Cited by 25 · see citing works

New directions towards safer and effective vaccines for Alzheimer's disease.

Goñi, F., & Sigurdsson, E. M. (2005) · PubMed · Cited by 25 · see citing works

Harnessing the Immune System for Treatment and Detection of Tau Pathology

Congdon, E. E., Krishnaswamy, S., & Sigurdsson, E. M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132435 · Cited by 20 · see citing works

SERUM IgG BRAIN REACTIVE ANTIBODIES IN ALZHEIMER DISEASE AND DOWN SYNDROME

Kumar, M., Cohén, D., & Eisdorfer, C. (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802010-00006 · Cited by 20 · see citing works

Immunotherapy for Conformational Diseases

Sigurdsson, E. M. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698837 · Cited by 19 · see citing works

Alterations in neurofilaments and the transformation of the cytoskeleton in axons may provide insight into the aberrant neuronal changes of Alzheimer’s disease

Vickers, J. C., Kirkcaldie, M., Phipps, A. J., & King, A. E. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.07.012 · Cited by 18 · see citing works

Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation

Fialová, L., Bartoš, A., & Švarcová, J. (2017) · Biomedical Papers · doi:10.5507/bp.2017.038 · Cited by 15 · see citing works

Antibodies against small heat-shock proteins in Alzheimer’s disease as a part of natural human immune repertoire or activation of humoral response?

Papuć, E., Krupski, W., Kurys-Denis, E., & Rejdak, K. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1477-2 · Cited by 9 · see citing works

Serum antibodies to cholinergic neurons in Alzheimer's disease.

Michaelson, D. M., Chapman, J., Bachar, O., Korczyn, A. D., & Wertman, E. (1989) · PubMed · Cited by 9 · see citing works

Paraneoplastische Degeneration des Kleinhirns bei Ovarialkarzinom

Bartoš, A., Štourač, P., Rusina, R., Šejdová, M., & Velenská, Z. (2002) · Der Nervenarzt · doi:10.1007/s00115-002-1371-7 · Cited by 7 · see citing works

SERUM ANTIBODIES TO CHOLINERGIC NEURONS IN ALZHEIMER??S DISEASE

Michaelson, D. M., Chapman, J., Bachar, O., Feldon, J., Korczyn, A. D., & Wertman, E. (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802030-00025 · Cited by 5 · see citing works

Avidity of antineurocytoskeletal antibodies in Alzheimer's disease patients

Nosková, L., Fialová, L., Bartoš, A., & Zima, T. (2017) · Biomedical Papers · doi:10.5507/bp.2017.017 · Cited by 4 · see citing works

Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases

Kocurova, G., Říčný, J., & Ovsepian, S. V. (2022) · Theranostics · doi:10.7150/thno.72126 · Cited by 29 · see citing works

Common Neurodegeneration-Associated Proteins Are Physiologically Expressed by Human B Lymphocytes and Are Interconnected via the Inflammation/Autophagy-Related Proteins TRAF6 and SQSTM1

Nataf, S., Guillen, M., & Pays, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02704 · Cited by 25 · see citing works

Dysregulated Levels of Circulating Autoantibodies against Neuronal and Nervous System Autoantigens in COVID-19 Patients

Lavi, Y. B., Vojdani, A., Halpert, G., Sharif, Κ., Ostrinski, Y., Zyskind, I., Lattin, M. T., Zimmerman, J., Silverberg, J. I., Rosenberg, A. Z., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13040687 · Cited by 26 · see citing works

Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond

Garmendia, J. V., Sanctis, C. V. D., Das, V., Annadurai, N., Hajdúch, M., & Sanctis, J. B. D. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231017141636 · Cited by 27 · see citing works

Blood Neurofilament Light Chain in Different Types of Dementia

Gu, L., Shu, H., Wang, Y., & Wang, P. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230601123123 · Cited by 16 · see citing works

Tau-Reactive Endogenous Antibodies: Origin, Functionality, and Implications for the Pathophysiology of Alzheimer’s Disease

Hromádková, L., & Ovsepian, S. V. (2019) · Journal of Immunology Research · doi:10.1155/2019/7406810 · Cited by 17 · see citing works

Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer’s disease pathogenesis

Chatanaka, M. K., Sohaei, D., Diamandis, E. P., & Prassas, I. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2187342 · Cited by 15 · see citing works

Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis

Miteva, D., Vasilev, G., & Velikova, T. V. (2023) · Antibodies · doi:10.3390/antib12040081 · Cited by 14 · see citing works

Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer’s disease-associated markers in 3xTg-AD mice

Kapadia, M., Mian, M. F., Ma, D., Hutton, C. P., Azam, A., Narkaj, K., Cao, C., Brown, B., Michalski, B., Morgan, D., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00745-9 · Cited by 14 · see citing works

TDP-43–specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis

Nielsen, A. K., Folke, J., Owczarek, S., Svenstrup, K., Winge, K., Pakkenberg, B., Aznar, S., & Brudek, T. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000937 · Cited by 14 · see citing works

Anti-neurofilament antibodies and neurodegeneration: Markers and generators

Zmira, O., Halpern, A. I., & Drori, T. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577248 · Cited by 13 · see citing works

Detection of antibodies against the huntingtin protein in human plasma

Denis, H. L., Alpaugh, M., Alvarez, C., Fenyi, A., Barker, R. A., Chouinard, S., Arrowsmith, C. H., Melki, R., Labib, R., Harding, R., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04687-x · Cited by 6 · see citing works

CMV as a factor in the development of Alzheimer’s disease?

Blanck, G., Huda, T. I., Chobrutskiy, B. I., & Chobrutskiy, A. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111140 · Cited by 5 · see citing works

Large-scale seroepidemiology uncovers nephro-urological pathologies in persons with tau autoimmunityPreprint

Magalhães, A. D., Emmenegger, M., Cecco, E. D., Carta, M. C., Frontzek, K., Chincisan, A., Guo, J., Hornemann, S., & Aguzzi, A. (2021) · medRxiv · doi:10.1101/2021.11.24.21266833 · Cited by 4 · see citing works

Adult Neurogenesis in the Gut, Homeostatic Autoimmunity and Neurodegenerative Disease Biomarkers

Ovsepian, S. V., & O’Leary, V. B. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.09.019 · Cited by 3 · see citing works

Unraveling the Role of Proteinopathies in Parasitic Infections

Hurła, M., Pikor, D., Banaszek-Hurła, N., Drelichowska, A., Dorszewska, J., Kozubski, W. P., Kacprzak, E., & Paul, M. (2025) · Biomedicines · doi:10.3390/biomedicines13030610 · Cited by 2 · see citing works

Large-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunity

Magalhães, A. D., Emmenegger, M., De Cecco, E., Carta, M., Frontzek, K., Chincisan, A., Guo, J., Hornemann, S., & Aguzzi, A. (2025) · PLOS Biology · doi:10.1371/journal.pbio.3003488 · Cited by 2 · see citing works

The role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?

Chatanaka, M. K., Prassas, I., Masters, C. L., & Diamandis, E. P. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70484 · Cited by 1 · see citing works

Is there a role for B cells in Alzheimer's disease?

Charavner, E.-L., Fillatreau, S., & El Behi, M. (2026) · Cellular Immunology · doi:10.1016/j.cellimm.2026.105154

Identification of Medium-Length Antineurofilament Autoantibodies in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Wang, S., Xu, C., Sun, X., Zhou, Y., Shu, Y., Xia, S., Lu, Z., Qiu, W., Zhong, X., & Peng, L. (2020) · Journal of Clinical Neurology · doi:10.3988/jcn.2020.16.3.470

Serum neurofilament light chain in response to probiotics in bi-center, double-blind, randomized, placebo-controlled clinical trial (CleverAge Biota)

Fialová, L., Bartoš, A., Kalousová, M., Nosková, L., Zelenková, M., Slukova, M., & Zima, T. (2024) · Biomedical Papers · doi:10.5507/bp.2024.032

Additional file 1 of Differential effects of chronic immunosuppression on behavioral, epigenetic, and Alzheimer’s disease-associated markers in 3xTg-AD mice

Kapadia, M., Mian, M. F., Ma, D., Hutton, C. P., Azam, A. B., Narkaj, K., Cao, C., Brown, B., Michalski, B., Morgan, D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13619932

Is Alzheimer’s an Autoimmune Disease?

Corrada, B. R., & Speth, R. C. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05790-3

Plasma Autoantibodies Against Neurodegeneration-Related Antigens in Dementia and Elevated Chi3Li Autoantibodies in Mild Cognitive Impairment

Kocurova, G., Svabenska, Z., Klaschka, J., Bartoš, A., & Říčný, J. (2026) · Biomolecules · doi:10.3390/biom16040518

B1 Cells for Life

Rothstein, T. L. (2026) · Immunological Reviews · doi:10.1111/imr.70160

P2‐050: Lower serum antibodies against tau protein and heavy neurofilament in Alzheimer's disease

Bartoš, A., Fialová, L., Švarcová, J., & Řı́pová, D. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.2144 · Cited by 1 · see citing works

P1‐062: Cerebrospinal fluid and serum autoantibodies against neurocytoskeletal proteins in patients with Alzheimer's disease

Bartoš, A., Řı́pová, D., Švarcová, J., Čechová, L., Fialová, L., & Malbohan, I. M. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.341 · Cited by 3 · see citing works

P1‐063: Decreased levels of serum antibodies against different tau antigens in patients with Alzheimer disease

Bartoš, A., Řı́pová, D., Švarcová, J., Čechová, L., Fialová, L., & Malbohan, I. M. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.342 · Cited by 1 · see citing works

P2‐030: Increased intrathecal synthesis of antibodies against tau protein and heavy neurofilament in Alzheimer's disease

Bartoš, A., Fialová, L., Švarcová, J., & Řı́pová, D. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.733

Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament

Bartoš, A., Fialová, L., Švarcová, J., & Řı́pová, D. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.08.001 · Cited by 57 · see citing works